Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-11-29 5:11 pm Purchase | 13D | EQRx Inc. EQRX | Casdin Capital LLC | 56,297,042 13% | 56,297,042 (New Position) | View |
| 2022-11-28 4:06 pm Purchase | 13D | TENAYA THERAPEUTICS INC TNYA | Casdin Capital LLC | 6,427,200 9.9% | 2,840,382 (+79.19%) | View |
| 2022-10-11 2:09 pm Sale | 13D | Century Therapeutics Inc. IPSC | Casdin Capital LLC | 3,222,940 5.5% | -23,184 (-0.71%) | View |
| 2022-07-20 6:54 pm Unchanged | 13D | ABSCI CORP ABSI | Casdin Capital LLC | 7,718,593 8.3% | 0 (Unchanged) | View |
| 2022-04-08 5:07 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 37,582,346 32.74% | 37,582,346 (New Position) | View |
| 2022-02-14 09:27 am Purchase | 13G | Verve Therapeutics Inc. VERV | Casdin Capital LLC | 3,138,167 6.5% | 100,000 (+3.29%) | View |
| 2022-02-11 10:00 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Casdin Capital LLC | 3,901,589 6.64% | 555,554 (+16.60%) | View |
| 2022-02-11 9:57 pm Purchase | 13G | DERMTECH INC DMTK | Casdin Capital LLC | 1,745,000 5.87% | 375,000 (+27.37%) | View |
| 2022-02-11 9:56 pm Sale | 13G | INVITAE CORP COM NVTAQ | Casdin Capital LLC | 12,203,669 5.39% | -94,369 (-0.77%) | View |
| 2021-08-19 4:59 pm Purchase | 13G | Tango Therapeutics Inc. TNGX | Casdin Capital LLC | 5,487,910 6.3% | 5,487,910 (New Position) | View |
| 2021-08-09 2:06 pm Purchase | 13D | TENAYA THERAPEUTICS INC TNYA | Casdin Capital LLC | 3,586,818 8.7% | 3,586,818 (New Position) | View |
| 2021-08-03 5:16 pm Purchase | 13G | MAXCYTE INC MXCT | Casdin Capital LLC | 13,971,334 14.2% | 13,971,334 (New Position) | View |
| 2021-07-29 2:11 pm Purchase | 13D | Century Therapeutics Inc. IPSC | Casdin Capital LLC | 3,246,124 5.9% | 3,246,124 (New Position) | View |
| 2021-07-29 1:12 pm Purchase | 13D | ABSCI CORP ABSI | Casdin Capital LLC | 7,718,593 8.5% | 7,718,593 (New Position) | View |
| 2021-06-23 11:38 am Purchase | 13G | Verve Therapeutics Inc. VERV | Casdin Capital LLC | 3,038,167 6.6% | 3,038,167 (New Position) | View |
| 2021-02-11 10:28 am Sale | 13G | Gritstone bio Inc. GRTS | Casdin Capital LLC | 0 0% | -2,160,000 (Position Closed) | View |
| 2021-02-11 10:25 am Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Casdin Capital LLC | 3,346,035 6.93% | 247,913 (+8.00%) | View |
| 2021-02-11 10:23 am Purchase | 13G | Fulcrum Therapeutics Inc. FULC | Casdin Capital LLC | 1,241,176 4.52% | 1,891 (+0.15%) | View |
| 2021-02-11 10:19 am Purchase | 13G | INVITAE CORP COM NVTAQ | Casdin Capital LLC | 12,298,038 6.37% | 3,264,095 (+36.13%) | View |
| 2021-02-11 10:17 am Sale | 13G | DERMTECH INC DMTK | Casdin Capital LLC | 1,370,000 6.99% | -58,571 (-4.10%) | View |